ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2018

Abstract Number: 1420

Prospective Validation of Cone Beam Computed Tomography for the Assessment of Disease Progression in Linear Scleroderma of the Face

Alessandra Meneghel1, Stefano Puggina2, Eleni Kamburi3, Giorgia Martini3, Fabio Vittadello3 and Francesco Zulian1, 1University of Padua, Department of Woman and Child Health, Padua, Italy, 2Unix Radiology Service, Affidea Group, Piove di Sacco, Italy, 3Department of Woman and Child Health, University of Padua, Padua, Italy

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2018

Keywords: Assessment, Morphea, outcome measures and scleroderma

Session Information

Date: Monday, October 22, 2018

Title: Pediatric Rheumatology – Clinical Poster II: Autoinflammatory Disorders, Scleroderma, and Miscellaneous

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Currently, the techniques used for the monitoring of Localized Scleroderma of the face (LSF) have significant limitations. We prospectively evaluated the reliability of the Cone Beam Computed Tomography (CBCT), a non-invasive, reproducible technique with a radiation dose lower than a conventional CT, to quantify changes of facial asymmetry over time as compared with the clinical and instrumental methods currently in use.

Methods: Consecutive patients with LSF, followed from January 2009 to December 2017 at our Pediatric Rheumatology Center, entered the study. CBCT was carried out following the same method previously described1. Measurements of total thickness, soft tissue and bone thickness were taken in both affected and unaffected sides of the case. These data allowed us to calculate the Absolute Rate of Change (ARC) of the lesion over time and the comparison with the ARC obtained from the healthy side, allowed us to calculate the Relative Rate of Change (RRC). The judgment of stability or worsening of the lesion was compared with the one derived from the physician global assessment (PGA), infrared teletermography (IT) and sequential clinical photographs (SCP). The Sensitivity-to-change of CBCT was assessed by Standardized Response Mean (SRM) and Effect Size (ES).

Results: 26 subjects with LSF, 15 females and 11 males, mean age 7.6 years (range 1.2-17.8) entered the study. 18 patients presented Parry Romberg syndrome (PRS), 5 En coup de sabre (ECDS) and 3 facial hemiatrophy (FH). The disease duration at the first CBCT was 3.7 years (range 0-28). During the study period, 69 CBCTs have been performed. On average, each patient underwent 2.7 CBCTs, 15 patients underwent two CBCTs, 8 patients three, and one patient 4, 5 or 6 CBCTs each, respectively. In all, the total thickness of the affected and unaffected side were evaluated. A worsening of CBCT with RRC > 5%, was found in 10 out of 40 evaluations (25%). The agreement between the CBCT and SCP was found in 20 out of 37 evaluations (54%). The comparison of the four clinical-instrumental methods performed in 40 evaluations, revealed an overall agreement of 66.7%. CBCT results were consistent with the PGA in 67.6% evaluations, with IT in 62.2%. The sensitivity to change of CBCT over time was very good at the mandibular condyle level (SRM values ranging from 0.53 to 0.77, ES 0.40-0.50) on the healthy side. The affected side reported SMR and ES values <0.5.

Conclusion: CBCT is an innovative technique that allows to assess the changes of the affected side, usually the non-growth, of LSF in comparison with the healthy side, during the developmental phase of pediatric patients. CBCT represents a reliable and objective tool for monitoring LSF over time in association with the other clinical-instrumental methods currently in use. Its practical benefit lies in its potential of correctly addressing therapeutic changes including the timing of start the reconstructive surgical process.

1.Di Giovanni C. et al. Cone beam computed tomography for the assessment of linear scleroderma of the face. Pediatric Rheumatology 2018; 16: 1.


Disclosure: A. Meneghel, None; S. Puggina, None; E. Kamburi, None; G. Martini, None; F. Vittadello, None; F. Zulian, None.

To cite this abstract in AMA style:

Meneghel A, Puggina S, Kamburi E, Martini G, Vittadello F, Zulian F. Prospective Validation of Cone Beam Computed Tomography for the Assessment of Disease Progression in Linear Scleroderma of the Face [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/prospective-validation-of-cone-beam-computed-tomography-for-the-assessment-of-disease-progression-in-linear-scleroderma-of-the-face/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prospective-validation-of-cone-beam-computed-tomography-for-the-assessment-of-disease-progression-in-linear-scleroderma-of-the-face/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology